3 In the REIMAGINE 1 trial, the most commonly reported adverse events (AEs) were gastrointestinal (GI)-related, occurring in 33/62 (53%) participants in the CagriSema 2.4 mg/2.4 mg group, 28/63 (44%) participants in the CagriSema 1 mg/1 mg group, and 13/64 (20%) participants in the placebo group
CBT focuses on identifying and changing unhelpful thought patterns, while ACT focuses on accepting difficult feelings and committing to actions that align with your values
Can Semaglutide Impact Mood
The body becomes more accustomed to the medication, and gastrointestinal issues typically diminish over time
Specific needs of dopamine neurons for stimulation in order to survive: implication for Parkinson disease
Progressive tapering of conventional medications as peptide effects develop represents a logical clinical strategy, ideally under medical supervision